GB0001315D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0001315D0
GB0001315D0 GBGB0001315.1A GB0001315A GB0001315D0 GB 0001315 D0 GB0001315 D0 GB 0001315D0 GB 0001315 A GB0001315 A GB 0001315A GB 0001315 D0 GB0001315 D0 GB 0001315D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
terbinafine
disintegrant
taste
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0001315.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0001315.1A priority Critical patent/GB0001315D0/en
Publication of GB0001315D0 publication Critical patent/GB0001315D0/en
Priority to PCT/EP2001/000562 priority patent/WO2001052895A1/en
Priority to US10/181,639 priority patent/US20030017200A1/en
Priority to AU2001230195A priority patent/AU2001230195A1/en
Priority to ES01902337T priority patent/ES2241777T3/es
Priority to EP01902337A priority patent/EP1259261B1/en
Priority to PT01902337T priority patent/PT1259261E/pt
Priority to AT01902337T priority patent/ATE297760T1/de
Priority to DE60111503T priority patent/DE60111503T2/de
Priority to JP2001552942A priority patent/JP2003520252A/ja
Priority to US12/758,145 priority patent/US20100197804A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0001315.1A 2000-01-20 2000-01-20 Organic compounds Ceased GB0001315D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds
JP2001552942A JP2003520252A (ja) 2000-01-20 2001-01-18 テルビナフィン含有医薬組成物
ES01902337T ES2241777T3 (es) 2000-01-20 2001-01-18 Composiciones farmaceuticas que contienen terbinafina.
US10/181,639 US20030017200A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine
AU2001230195A AU2001230195A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine
PCT/EP2001/000562 WO2001052895A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine
EP01902337A EP1259261B1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine
PT01902337T PT1259261E (pt) 2000-01-20 2001-01-18 Composicoes farmaceuticas que compreendem terbinafina
AT01902337T ATE297760T1 (de) 2000-01-20 2001-01-18 Pharmazeutische zusammensetzungen enthaltend terbinafin
DE60111503T DE60111503T2 (de) 2000-01-20 2001-01-18 Pharmazeutische zusammensetzungen enthaltend terbinafin
US12/758,145 US20100197804A1 (en) 2000-01-20 2010-04-12 Pharmaceutical compositions comprising terbinafine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds

Publications (1)

Publication Number Publication Date
GB0001315D0 true GB0001315D0 (en) 2000-03-08

Family

ID=9884039

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0001315.1A Ceased GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds

Country Status (10)

Country Link
US (2) US20030017200A1 (enExample)
EP (1) EP1259261B1 (enExample)
JP (1) JP2003520252A (enExample)
AT (1) ATE297760T1 (enExample)
AU (1) AU2001230195A1 (enExample)
DE (1) DE60111503T2 (enExample)
ES (1) ES2241777T3 (enExample)
GB (1) GB0001315D0 (enExample)
PT (1) PT1259261E (enExample)
WO (1) WO2001052895A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
RU2214237C1 (ru) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Противогрибковое средство "брамизил"
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CA3063288A1 (en) 2017-05-12 2018-11-15 Mavalon Therapeutics Limited Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors
CN110200929A (zh) * 2018-12-14 2019-09-06 悦康药业集团上海制药有限公司 一种含有盐酸特比萘芬的口服片及其制备方法
CN109674757A (zh) * 2019-02-22 2019-04-26 济南康和医药科技有限公司 一种盐酸特比萘芬组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
US4894592A (en) * 1988-05-23 1990-01-16 Fusion Systems Corporation Electrodeless lamp energized by microwave energy
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
RU2184570C2 (ru) * 1997-09-30 2002-07-10 Дайити Фармасьютикал Ко., Лтд. Препараты для орального введения
JP2000086503A (ja) * 1998-09-07 2000-03-28 Pola Chem Ind Inc 錠剤医薬組成物

Also Published As

Publication number Publication date
US20030017200A1 (en) 2003-01-23
EP1259261A1 (en) 2002-11-27
JP2003520252A (ja) 2003-07-02
ES2241777T3 (es) 2005-11-01
DE60111503D1 (de) 2005-07-21
US20100197804A1 (en) 2010-08-05
DE60111503T2 (de) 2006-05-18
WO2001052895A1 (en) 2001-07-26
PT1259261E (pt) 2005-10-31
ATE297760T1 (de) 2005-07-15
AU2001230195A1 (en) 2001-07-31
EP1259261B1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
GEP20074047B (en) Pramipexole once-daily dosage form
MXPA03007215A (es) Formulaciones farmaceuticas.
MXPA03006775A (es) Formulacion farmaceutica.
IL180710A0 (en) Controlled-release, injectable pharmaceutical implant
IL151685A0 (en) Polyglutamic acid-camptothecin conjugates, methods for the preparation thereof and pharmaceutical compositons containing the same
MXPA03007641A (es) Formulacion farmaceutica.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
MXPA03004941A (es) Formulacion farmacologica que tiene tolerancia por via oral mejorada.
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
AP2004003046A0 (en) Dosage regimen and pharmaceutical composition for emergency contraception.
ZA200210359B (en) Pharmaceutical compositions.
GB0001315D0 (en) Organic compounds
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
AP2004003066A0 (en) Pharmaceutical compositions based on azetidine derivatives.
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
MXPA03009689A (es) TABLETA FARMACEUTICA QUE TIENE ALTO CONTENIDO DE INGREDIENTE FARMACeUTICO ACTIVO (IFA).
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
MY142129A (en) Amorphous lercanidipine hydrochloride
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)